GlassScriptPhysician profile
Steven C Karr
NPI 1871564153
$5,823.15
in general payments reported to CMS, 2019-2025
20 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $125 · 2021: $384 · 2022: $589 · 2023: $2,176 · 2024: $765 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,063.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenacare Global, LLC | $1,599.81 | 2023-2024 | |
| Stryker Corporation | $1,369.60 | 2022-2025 | Ortholoc 2 Lapifuse, Actishield, Dart-Fire |
| Treace Medical Concepts, INC. | $639.69 | 2021-2025 | |
| Wright Medical Technology, INC. | $478.32 | 2019-2020 | |
| Smith+Nephew, INC. | $396.64 | 2019-2024 | Renasys Touch, Pico 7, Stravix |
| Depuy Synthes Sales INC. | $263.03 | 2024-2025 | N/A, Hammerlock |
| Paragon 28, INC. | $240.06 | 2020-2024 | Ttc Nail, Portfolio |
| Osteomed LLC | $203.60 | 2021-2022 | |
| Kerecis Limited | $164.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $108.03 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $80.15 | 2025 | |
| Bioventus LLC | $67.35 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $52.88 | 2021-2022 | |
| Medtronic, INC. | $37.43 | 2023-2025 | Inceptiv, Endurant Iis |
| Aroa Biosurgery Incorporated | $29.78 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $26.53 | 2023 | |
| Nevro Corp. | $20.55 | 2022 | |
| Linvatec Corporation | $19.14 | 2022 | |
| Acera Surgical, INC. | $14.08 | 2024 | Restrata Wound Matrix |
| Anika Therapeutics, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Karr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.